Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review

By Storms William   Bowdish Matthew S.   Farrar Judith R.  

Allergy and Asthma Proceedings, Vol. 33, Iss. 2, 2012-03 ,pp. : 172-177

OceanSide Publications, Inc

Access to resources Recommend Favorite

Omalizumab in asthma: Approval and postapproval experience

By Chiang Dean   Clark Justin   Casale Thomas  

Clinical Reviews in Allergy and Immunology, Vol. 29, Iss. 1, 2005-02 ,pp. : 3-16

Humana Press, Inc

Access to resources Recommend Favorite

Nebulized dehydroepiandrosterone-3-sulfate improves asthma control in the moderate-to-severe asthma results of a 6-week, randomized, double-blind, placebo-controlled study

By Wenzel Sally E.   Robinson Cynthia B.   Leonard Joanne M.   Panettieri Reynold A.  

Allergy and Asthma Proceedings, Vol. 31, Iss. 6, 2010-11 ,pp. : 461-471

OceanSide Publications, Inc

Access to resources Recommend Favorite

Impact of Changes in Asthma Severity on Health-Related Quality of Life in Pediatric and Adult Asthma Patients: Results from The Asthma Outcomes Monitoring System

By Graham Donna M.   Blaiss Michael S.   Bayliss Martha S.   Espindle Derek M.   Ware John E.  

Allergy and Asthma Proceedings, Vol. 21, Iss. 3, 2000-05 ,pp. : 151-158

OceanSide Publications, Inc

Access to resources Recommend Favorite

Risk factors for asthma symptoms at school age: An 8-year prospective study

By Morais-Almeida Marco   Gaspar Ângola   Pires Graça   Prates Sara   Rosado-Pinto José  

Allergy and Asthma Proceedings, Vol. 28, Iss. 2, 2007-03 ,pp. : 183-189

OceanSide Publications, Inc

Access to resources Recommend Favorite